Attenuation of obesity and related metabolic disorders by the individual or combination treatment with IL-2/anti-IL-2 complex and hyperbaric oxygen
Eun-Jeong ChoiiD, Hyung-Ran Kim, Kie Jeong-Hae, Byung-In Moon, Ju-Young Seoh
Abstract
Obesity is the disease accumulating excessive fat in the body. The prevalence of obesity and related metabolic disorders is increasing every year worldwide. Immunologically, obesity is a chronic low-grade inflammatory state with the increase of M1 macrophages and decrease of regulatory T cells (Tregs). IL-2/anti-IL-2 complex (IL-2C) and hyperbaric oxygen (HBO) are known to expand Tregs in vivo and suppress inflammation. Therefore, in this study, IL-2C and HBO were investigated for the preventive effect of obesity and related metabolic disorders. Male C57BL/6 mice were fed with a high-fat diet (HFD) for 16 weeks, and counterparts were fed with a low-fat diet (LFD). At the end of the experiment, the body weight gain and impaired glucose metabolism, elevated levels of insulin and total cholesterol induced by HFD were improved by the individual or combination treatment with Il-2C and HBO. Histological examination of the epididymal white adipose tissue showed adipocyte hypertrophy and many crown-like structures in the HFD control groups. In addition, the liver showed the progression of non-alcoholic fatty liver disease (NAFLD) in the HFD control groups, but it was significantly improved by the individual or combination treatment with IL-2C and HBO.\n\nAs for the underlying mechanism, inflammation induced by obesity was decreased, and HIF-1 expression by adipocyte hypertrophy was also reduced by the individual or combination treatment with IL-2C and HBO. In addition, adipose tissue browning was activated in brown and inguinal adipose tissue, and the expression of UCP-1 involved in the thermogenesis was increased by the individual or combination treatment with IL-2C and HBO. Overall, these results suggested that IL-2C and HBO might be a new promising immunotherapy for the treatment of obesity and related metabolic disorders by regulation of inflammation and activation of adipose tissue browning.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- IL-25 induces beige fat to improve metabolic homeostasis via macrophage and innervation
Lingyi Li, Lei Ma, … Zhonghan Yang·bioRxiv·Nov 19, 2018
- iRhom2 serves as a facilitator in obesity by enhancing adipose inflammation and insulin resistance
- Anabolic lipid metabolism regulates adipose type 2 innate lymphoid cell differentiation to maintain metabolic health
Maria Rafailia Theodorou, Jiangyan Yu, … Christoph Wilhelm·bioRxiv·Mar 26, 2024
- Bone marrow adipocytes drive the development of tissue invasive Ly6Chigh monocytes during obesity
P. Boroumand, D. Prescott, … A. Klip·bioRxiv·Dec 7, 2020
- CD11c+ Tbet+ B cells constrain obesity- and vaccination-induced germinal center B cells and T helper cells
Carlo Vanz, Benjamin T. Enslow, … Elizabeth A. Leadbetter·bioRxiv·Sep 1, 2025
- Targeting IRE1alpha improves insulin sensitivity and thermogenesis and suppresses metabolically active adipose tissue macrophages in male obese mice
Dan Wu, Venkateswararao Eeda, … Weidong Wang·bioRxiv·Jul 17, 2024